Monoclonal antibody targets, kills leukemia cells

Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.The findings, published in the online Early Edition of the Proceedings of the National Academy of Sciences on March 25, 2013 represent a potential new therapy for treating at least some patients with CLL, the most common type of blood cancer in the United States.

Read more:
Monoclonal antibody targets, kills leukemia cells

Source: Science Daily

Art and Science of Laboratory Medicine

Web site: laboratoryeqas.exai.com

Facebook: www.facebook.com/LaboratoryEQAS

Twitter: LaboratoryEQAS